Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Researchers call for further ethical discussions of adaptive clinical trials

Despite a growing interest in adaptive clinical trial (ACT) designs, few designs have been used relative to the overall number of trials conducted, and more ethical concerns need to be considered, according to a new study published Sunday from University of Michigan researchers in BioMedCentral .

Scientists target Hep C virus using CRISPR-Cas technology

Scientists in the US have used the CRISPR-Cas system to target the RNA of hepatitis C virus (HCV).

FDA calls on manufacturers to begin switch from batch to continuous production

Though making the switch from batch to continuous manufacturing may be difficult, costly and time consuming, pharma manufacturers and CMOs should begin to consider the switch as in the long-run it will end up saving companies time, money and space, FDA’s CDER Director Janet Woodcock told congressmen in a hearing...

Roundup of CRO partnerships, offerings and other news

A number of small, mid-sized and large CROs (contract research organizations) and other companies tied to the world of clinical research have announced various partnerships and other financial moves over the past week. Here’s a roundup of the latest:

Alkermes: Sale of 'non-core' CMO unit supports blossoming portfolio

Alkermes will continue to streamline its manufacturing to support a growing portfolio following the sale of its legacy CMO site.

Key Industry Events